Palico, the private equity fund marketplace

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

Overview of Medical Research Commercialisation Fund

Medical Research Commercialisation Fund is a closed private equity fund managed by Brandon Capital Partners.

2007
Vintage
AUD 51m
Size
Buy and sell stakes in Medical Research Commercialisation Fund

Access a unique secondary deal flow.
Find potential buyers without revealing your identity.

Already a member? Log in.

News about Medical Research Commercialisation Fund

Jun 03, 2015

Auspherix, an early stage anti-infectives company based in Australia, raised £6m in Series A funding from Imperial Innovations and MRCF.

Feb 10, 2015

Vaxxas, a biotechnology company commercializing a novel vaccination platform, secured $20m in Series B funding from OneVentures and others.

Jan 19, 2015

The Medical Research Commercialisation Fund, managed by Brandon Capital Partners, invested AU$2m in Solvanix, an Australian biotech company.

Read more news about Medical Research Commercialisation Fund

Manager of Medical Research Commercialisation Fund

Brandon Capital Partners logo

Brandon Capital Partners

Australia

Brandon Capital Partners is a private equity general partner firm headquartered in Melbourne, Victoria, Australia and has other offices in Australia and United States.

Funds managed by Brandon Capital Partners

Closed and liquidated funds managed by Brandon Capital Partners:
Fund name Size Vintage Status
Biomedical Translation Fund AUD 500m 2016 Closed
Brandon Bioscience Fund No. 1 AUD 50m 2008 Closed
Medical Research Commercialisation Fund AUD 51m 2007 Closed
Invest in Private Equity

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

Already a member? Log in.